Cancer Therapy Market Growth Accelerated by Rapid Adoption of Novel Therapies

 


Cancer therapy involves the use of drugs, radiation, immunotherapy, and surgery to treat various types of cancers. Advances in cancer biology and technology have enabled the development of novel targeted therapies and immunotherapies with improved efficacy and lesser side effects compared to conventional therapies. Monoclonal antibodies, immune checkpoint inhibitors, and personalized therapeutic vaccines have emerged as promising treatment options. The global Cancer Therapy Market is estimated to be valued at US$ 231671.29 Bn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The rapid adoption of novel therapies has been a key trend boosting the growth of the cancer therapy market size. Targeted therapies and immunotherapies have revolutionized the treatment of various cancers. For example, immune checkpoint inhibitors have shown promising results in treating lung cancer, melanoma, and other types of cancers. Drugs such as pembrolizumab, nivolumab, and atezolizumab have received regulatory approvals for treating different types and stages of cancers. The success of immunotherapies has fueled investments in developing new immune-based drug candidates. Several immunotherapies are in late stages of clinical trials. If approved, these novel drug candidates are expected to get adopted at a larger scale, thereby propelling the market growth during the forecast period.

Segment Analysis
The global cancer therapy market is dominated by chemotherapy sub segment accounting for around 30% share of the total market. Chemotherapy remains the most common form of cancer treatment due to its cost-effectiveness and ability to treat widespread cancer cases. It has shown success in treating various cancers including breast cancer, lung cancer, and colorectal cancer.

Key Takeaways
The global cancer therapy market is expected to witness high growth over the forecast period owing to rising cancer prevalence worldwide. According to WHO, cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040.

Regional analysis: North America dominates the global cancer therapy market and is anticipated to maintain its leading position during the forecast period as well. Higher adoption of advanced cancer therapies along with presence of well-established healthcare industry and favorable reimbursement policies are some factors driving the cancer therapy market growth in the region. Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising healthcare expenditure, improving access to diagnostic and treatment facilities, and high prevalence of various cancers in major Asian countries.

Key players operating in the cancer therapy market are GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, PLANMED OY, and Barco.

Get more insights on this topic: https://www.ukwebwire.com/cancer-therapy-market-share-and-opportunity-analysis/

Comments

Post a Comment

Popular posts from this blog

Blast Chillers Market Poised to Witness High Growth Owing to Rising Focus on Food Safety

Image
  Blast Chillers Market Blast chillers, also known as shock freeze machines, are appliances used to quickly cool or freeze food items that have been cooked. Blast chillers allow rapid and accurate chilling of cooked or cooked/hot foods quickly to temperatures that inhibit the growth of harmful bacteria. This rapid chilling process helps restaurants, cafes, caterers and foodservice distributors maintain food quality as well as meet critical food safety regulations. Blast chillers help in preserving the look, texture, flavor and nutritional value of foods even after rapid chilling. They extend the shelf life of cooked foods by preventing bacterial growth in the food's temperature danger zone — between 4°C and 60°C. With increasing focus on food safety, hygiene and quality across the foodservice industry, demand for blast chillers has been rising significantly. The Global blast chillers market is estimated to be valued at US$ 2.24 Bn in 2024 and is expected to exhibit a CAGR of 15%...
Read more

Driving Forces and Strategic Insights: Unveiling Growth Opportunities in the Global Pharma 4.0 Market

Image
  Global Pharma 4.0 Market The Global Pharma 4.0 Market is witnessing unprecedented growth driven by several factors. One of the key market drivers is the increasing adoption of digitalization and automation in the pharmaceutical industry. Pharma 4.0 represents the integration of advanced technologies such as artificial intelligence, big data analytics, Internet of Things (IoT), and robotics into pharmaceutical manufacturing and supply chain processes. This integration enhances efficiency, reduces costs, and improves the quality of pharmaceutical products. Additionally, the rising demand for personalized medicine and the need for efficient drug development processes are further fueling the growth of the Global Pharma 4.0 Market. The Global Pharma 4.0 Market is estimated to be valued at   US$ 54.43 Bn in 2024 and is expected to exhibit a CAGR of 18.3% over the forecast period from 2024 to 2031.   Conducting a PEST analysis provides insights into the external facto...
Read more

Navigating Growth: Insights into the Global Flea, Tick, and Heartworm Products Market

Image
  Global Flea, Tick, and Heartworm Products Market The Global Flea, Tick, and Heartworm Products Market have witnessed robust growth in recent years, driven by several key factors. Market drivers such as increasing pet ownership, rising awareness about pet health, and the growing prevalence of flea, tick, and heartworm infections among pets are propelling the demand for related products. Furthermore, advancements in veterinary medicines and the introduction of novel products with improved efficacy are augmenting market growth. The rising disposable income and changing lifestyles, particularly in emerging economies, have also contributed significantly to the expansion of the Global Flea, Tick, and Heartworm Products Market. The Global Flea, Tick, and Heartworm Products Market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031. Conducting a PEST analysis provides valuable insights into the external f...
Read more